skip to navigation skip to content

Business Weekly: Near-death experience breathes life into small molecule startup


A feature about PharmEnable startup, that is exploring new areas of chemical space that no one else is currently searching to enable the development of vital new medicines. The startup is currently on the Accelerate Cambridge programme run by the Entrepreneurship Centre. Co-founder Dr Hannah Sore commented: “I knew I wanted to disrupt the sector and improve drug discovery. But how to do that was the initial issue. I knew I wanted to run a company I could scale. For my own part that meant developing a completely different skill set when I co-founded PharmEnable.”

Read the full article []